Exodus Point Capital Management, LP Ampio Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $754,397 - $957,504	-483,588 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $515,644 - $944,083	379,150 Added 363.04%	483,588 $817,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $78,328 - $288,248	104,438 New	104,438 $166,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.